Operating Lease, Right-of-Use Asset in USD of Cytek Biosciences, Inc. from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cytek Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2021 to Q3 2025.
  • Cytek Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $11.2M, a 10.2% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cytek Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $11.2M +$1.03M +10.2% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $16.4M +$7.06M +75.7% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $9.87M -$80K -0.8% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $10.2M -$685K -6.31% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 $10.1M -$1.58M -13.5% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $9.33M -$3.1M -24.9% 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $9.95M -$3.24M -24.6% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $10.9M -$3.03M -21.8% 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $11.7M -$2.71M -18.8% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $12.4M -$1.21M -8.89% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $13.2M -$696K -5.01% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $13.9M +$13.9M 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 $14.4M 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $13.6M 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $13.9M 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $0 31 Dec 2021 10-K 01 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.